Fabian Somers

Title: The Innovative Journey of Inventor Fabian Somers

Introduction

Fabian Somers, a prominent inventor based in Neupre, Belgium, has made significant contributions to the field of pharmaceutical formulations. With his expertise and innovative thinking, he has developed a patented technology that enhances the stability of pharmaceutical protein formulations using small peptides.

Latest Patents

Somers holds a patent for the "Stabilization of pharmaceutical protein formulations with small peptides." This invention introduces stable pharmaceutical protein formulations that utilize peptide stabilizers, including Gly-Gly, Gly-Gly-Gly, Gly-Tyr, Gly-Phe, Gly-His, Gly-Asp, Gly-Ala, Ala-Gly, Ala-Ala, and their derivatives and mixtures. Additionally, his patent incorporates erythropoietin in the formulations, combined with various dipeptides, tripeptides, tetrapeptides, pentapeptides, and other mixtures. Notably, these formulations may also include surfactants to further enhance stability.

Career Highlights

Throughout his career, Fabian Somers has collaborated with reputable organizations to advance his research and innovations. He has gained experience working at Baxter International Inc. and Baxter Healthcare SA, where he contributed to the development of pharmaceutical products.

Collaborations

Fabian has worked closely with his coworker, Dirk Faict, collaborating on various projects aimed at improving pharmaceutical formulations. Their combined expertise has paved the way for innovative solutions in the industry.

Conclusion

Fabian Somers represents a key figure in the world of pharmaceutical innovations. His patented work on stabilizing protein formulations with small peptides showcases his dedication to advancing medical technology and improving patient outcomes. As the field of pharmaceuticals continues to evolve, Somers’ contributions will undoubtedly play a vital role in future developments.